Literature DB >> 16207974

Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.

Pierre Nicolas1, Gunnstein Norheim, Eric Garnotel, Saacou Djibo, Dominique A Caugant.   

Abstract

At the two World Health Organization Collaborating Centers for Reference and Research on Meningococci in Marseilles, France, and Oslo, Norway, the multilocus sequence typing technique was used for the characterization of a total of 357 strains of meningococci isolated from meningitis cases in 13 African countries of the meningitis belt between 1988 and 2003. Among these strains, 278 of 357 (77.9%) belonged to the sequence type 5 (ST-5) complex; 23.2% were ST-5 and 53.5% were ST-7. ST-5 was probably introduced in Africa in 1987 and was responsible for most of the meningitis cases between 1988 and 2001. ST-7 emerged in the mid-1990s and has totally replaced ST-5 since 2002. These two STs characterized serogroup A strains and have been responsible for hundreds of thousands of cases. Fifty-two strains (14.3%) belonged to the ST-11 complex. The ST-11 complex was characterized by serogroup W135, which has been responsible for an increasing number of sporadic cases since 2000 and the first W135 epidemic ever seen in Africa (in Burkina Faso in 2002). Identification of W135 ST-11 strains in many countries is a great concern for the region. Apart from these two major clonal complexes, a few other clones, such as ST-2881, ST-181, and ST-751, were sporadically detected. Careful surveys for these clones need to be conducted, but at present they play only a minor role in the overall epidemiology of meningococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207974      PMCID: PMC1248450          DOI: 10.1128/JCM.43.10.5129-5135.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  The 1998 Senegal epidemic of meningitis was due to the clonal expansion of A:4:P1.9, clone III-1, sequence type 5 Neisseria meningitidis strains.

Authors:  P Nicolas; G Raphenon; M Guibourdenche; L Decousset; R Stor; A B Gaye
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  [CEREBROSPINAL MENINGITIS IN AFRICA].

Authors:  L LAPEYSSONNIE
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

3.  The relative contributions of recombination and mutation to the divergence of clones of Neisseria meningitidis.

Authors:  E J Feil; M C Maiden; M Achtman; B G Spratt
Journal:  Mol Biol Evol       Date:  1999-11       Impact factor: 16.240

4.  Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A sequence type (ST)-7 and serogroup W135 ST-11 or ST-2881 strains.

Authors:  P Nicolas; S Djibo; A Moussa; B Tenebray; P Boisier; S Chanteau
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Pharyngeal carriage of serogroup W135 Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan.

Authors:  P Nicolas; N Ait M'barek; S Al-Awaidy; S Al Busaidy; N Sulaiman; M Issa; J Mahjour; P Mölling; D A Caugant; P Olcén; M Santamaria
Journal:  APMIS       Date:  2005-03       Impact factor: 3.205

6.  [Pharyngeal carriage of Neisseria meningitidis in a school of Niamey, Niger].

Authors:  S Djibo; P Nicolas; G Campagne; J P Chippaux
Journal:  Med Trop (Mars)       Date:  2004

7.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Authors:  M C Maiden; J A Bygraves; E Feil; G Morelli; J E Russell; R Urwin; Q Zhang; J Zhou; K Zurth; D A Caugant; I M Feavers; M Achtman; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

8.  Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread.

Authors:  G Morelli; B Malorny; K Müller; A Seiler; J F Wang; J del Valle; M Achtman
Journal:  Mol Microbiol       Date:  1997-09       Impact factor: 3.501

9.  Capsule switching of Neisseria meningitidis.

Authors:  J S Swartley; A A Marfin; S Edupuganti; L J Liu; P Cieslak; B Perkins; J D Wenger; D S Stephens
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 10.  Population genetics and molecular epidemiology of Neisseria meningitidis.

Authors:  D A Caugant
Journal:  APMIS       Date:  1998-05       Impact factor: 3.205

View more
  39 in total

1.  W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina.

Authors:  Adriana M Efron; Cecilia Sorhouet; Celia Salcedo; Raquel Abad; Mabel Regueira; Julio A Vázquez
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

Review 2.  Bexsero® chronicle.

Authors:  George Vernikos; Duccio Medini
Journal:  Pathog Glob Health       Date:  2014-10       Impact factor: 2.894

3.  Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Zhongwu Guo
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

4.  Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.

Authors:  Noëlle Mistretta; Delphine Seguin; Jerôme Thiébaud; Sandrine Vialle; Frédéric Blanc; Marina Brossaud; Philippe Talaga; Gunnstein Norheim; Monique Moreau; Bachra Rokbi
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

Review 5.  Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Authors:  Mustapha M Mustapha; Lee H Harrison
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

6.  Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.

Authors:  Paul A Kristiansen; Fabien Diomandé; Rasmata Ouédraogo; Idrissa Sanou; Lassana Sangaré; Abdoul-Salam Ouédraogo; Absatou Ky Ba; Denis Kandolo; Jennifer Dolan Thomas; Thomas A Clark; Marie-Pierre Préziosi; F Marc Laforce; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

7.  Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.

Authors:  Sara Thulin Hedberg; Hans Fredlund; Pierre Nicolas; Dominique A Caugant; Per Olcén; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

8.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

9.  Meningococcal disease in South Africa, 1999-2002.

Authors:  Garry B Coulson; Anne von Gottberg; Mignon du Plessis; Anthony M Smith; Linda de Gouveia; Keith P Klugman
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

10.  Serogroup X in meningococcal disease, Western Kenya.

Authors:  Sadiki Materu; Helen S Cox; Petros Isaakidis; Bienvenu Baruani; Thomas Ogaro; Dominique A Caugant
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.